Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ariadna Tibau Martorell

Brigham and Women's Hospital

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (15)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (10)

Agusti BARNADAS

CHIEF OF THE DEPARTMENT

Hospital de la Santa Creu i Sant Pau

SPAIN

View details

Guanqiao Li

Assistant Professor / Special Research Fellow

Tsinghua University

CHINA

View details

Aurea Navarro-Sabate

Professor

University of Barcelona

SPAIN

View details

Bostjan Seruga

SLOVENIA

View details

Kerstin Noëlle Vokinger

Professor and Academic Chair for Regulation in Law, Medicine and Technology

University of Zurich

SWITZERLAND

View details

Mireia Margeli Vila

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Juan Rafael de la Haba Rodríguez

ESPECIALISTA ONCOLOGIA MÉDICA

Universidad de Córdoba

SPAIN

View details

Edward Cliff

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Eitan Amir

Medical Oncologist

University of Toronto

CANADA

View details

Sonia Servitja Tormo

Associate professor

Universitat Pompeu Fabra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ariadna Tibau Martorell

Research Interests

Make your next move.

Explore related searches

Articles (15)

Risk of bias and clinical benefit of phase III trials supporting FDA-approved anticancer medicines, 2018–2025: A cross-sectional analysis

Genetic Variation in <i>NR1I2</i> and Palbociclib Safety and Prognosis in Advanced Breast Cancer: An Exploratory Multicenter Study

High Cost of Cancer Medicines in the United States: Opportunities for Policy Reforms

Clinical implementation of multi-cancer early detection tests: can we find a path forward?

Efficacy and Toxicity Associated with Cancer Drug Approvals in Switzerland: International Implications

Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study

The Effect of Staging Intervals on Progression-Free Survival in Registration Studies of Oncologic Drugs: A Meta-Analysis

Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021

Will I feel better? Raising the bar for quality of life in oncology

Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA

Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study

Global cooperation and early access—clinical outcomes matter

Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies

Quality of life with palbociclib plus fulvestrant <i>versus</i> placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.

Collaborators (10)

Agusti BARNADAS

Guanqiao Li

Aurea Navarro-Sabate

Bostjan Seruga

Kerstin Noëlle Vokinger

Mireia Margeli Vila

Juan Rafael de la Haba Rodríguez

Edward Cliff

Eitan Amir

Sonia Servitja Tormo

Make your next move.